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Abstract.  The effect of 12-O-tetradeconylphorbol-13- 
acetate (TPA) on gap junction assembly between 
Novikoff hepatoma cells was examined.  Cells were 
dissociated with EDTA to single cells and then reag- 
gregated to form new junctions.  When TPA (25 riM) 
was added to the cells at the onset of the 60-min 
re,  aggregation,  dye transfer was detected at only 0.6 % 
of the cell-cell interfaces compared to 72 % for the 
untreated control and 74%  for 4-a TPA, an inactive 
isomer of TPA.  Freeze-fracture electron microscopy of 
reaggregated control cells showed interfaces containing 
an average of more than 600 aggregated intramem- 
branous gap junction particles,  while TPA-treated cells 
had no gap junctions.  However, Lucifer yellow dye 
transfer between nondissociated cells via gap junctions 
was unaffected by 60 rain of TPA treatment.  There- 
fore, TPA dramatically inhibited gap junction assem- 
bly but did not alter channel gating nor enhance disas- 
sembly of preexisting gap junction structures.  Short 
term TPA treatment (<30 min) increased phosphoryla- 
tion of the gap junction protein molecular weight of 
43,000 (Cx43), but did not change the cellular level of 
Cx43.  Cell surface biotinylation experiments suggested 
that TPA did not substantially reduce the plasma 
membrane concentration of Cx43.  Therefore, the sim- 
ple presence of Cx43 in the plasma membrane is not 
sufficient for gap junction assembly, and protein ki- 
nase C probably exerts an effect on assembly of gap 
junctions at the plasma membrane level. 
Ap junctions allow molecules of molecular weight of 
<1,000 to pass between cells (26) via matched mem- 
brane channels composed of proteins from the "con- 
nexin" gene family  (6).  Cell-cell communication  through 
these channels  is thought  to play an important role in the 
control of cell proliferation,  embryonic development,  cell 
differentiation,  and the regulation  of differentiated  function 
in postmitotic cells (4, 22). 
A number of studies  have documented a correlation  be- 
tween neoplastic  transformation  and reduced gap junctional 
intercellular communication (e.g., references 2, 3, 10). Many 
laboratories have also confirmed the original reports (32, 57) 
that tumor promoters reduce gap junctional communication 
between cells grown in tissue culture. As a result of these and 
other  studies,  reduced cell-cell communication  has  been 
proposed  as  a  critical  step  in  multistage  carcinogenesis 
(13, 51). 
A common method used to study gap junctional communi- 
cation is the intracellular  microinjection of tracer dyes that 
can pass through gap junction channels.  The tumor promo- 
ter  12-O-tetradeconylphorbol-13-acetate  (TPA)  ~ has  been 
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shown to reduce dye spread in a wide variety of animal cell 
types (33). Since the maximal decrease in dye transfer usu- 
ally requires 1-2 h to occur (e.g., 1, 9,  15, 44), the mecha- 
nism by which TPA addition decreases gap junction activity 
is not evident. However, treatment of cells with TPA for sev- 
eral hours has been shown to significantly reduce the number 
of gap junctions  as  assayed  by  freeze-fracture  electron 
microscopy (53, 55). These results have been supported re- 
cently by immunofluorescence  studies  which  have  docu- 
mented reductions  in punctate labeling of connexin antibod- 
ies  at  the  plasma  membrane  after  30  min-2  h  of TPA 
treatment  (1, 5, 9). A study on nucleotide transfer  has also 
indicated that TPA may have some effects on gap junction as- 
sembly based on a reduction in the rate of appearance  of gap 
junctional communication  (40). In a few cases, no change or 
an increase (31) in junctional conductance has been observed 
with TPA treatment.  Since the time course and extent of TPA 
effects on gap junctional communication  seem to vary with 
cell type, it has been difficult to determine the mechanism(s) 
of TPA reduction  in gap junctional communication. 
TPA, a specific regulator of protein kinase C activity (38), 
could affect a wide variety  of cellular processes related  to 
gap junction  communication.  Protein  kinase  C  has  been 
reported to directly phosphorylate connexins with molecular 
weights of 32,000 and 43,000 (Cx43) (45, 46, 48, 49). Phos- 
phorylation of gap junction proteins could regulate channel 
opening  and closing  (gating) or channel  assembly or turn- 
over. Gap junction assembly could be regulated  when con- 
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tive hexamers of connexins (referred to  as  connexons or 
hemi-channels)  are  being  assembled  into  gap  junctions 
within the plasma membrane. 
Gap junction assembly can be readily studied with Novi- 
koff hepatoma cells, which can be grown in suspension cul- 
ture  and readily dissociated without proteases  in EDTA- 
supplemented medium (16). A  90-min incubation period 
with agitation allows the dissociated cells to eliminate exist- 
ing gap junction structures, so at the end of this "recovery" 
period more than 95 % of the cells are single ceils without 
any gap junction structures (41). When the cells are allowed 
to make contact and "reaggregate; new gap junctions form. 
Gap junction assembly can then be assayed in a quantitative 
manner with dye permeability and freeze-fracture electron 
microscopy. We have studied the influence of TPA on gap 
junction assembly using this system. 
Materials and Methods 
Cell Culture and Dissociation 
Tissue culture reagents were purchased from GIBCO-BRL (Galthersburg, 
MD). The Novikoff hepatoma cell line (N1S1-67) was maintained and dis- 
sociated as previously described (27).  Briefly,  cells in logarithmic growth 
were dissociated by centrifugation from standard growth medium ($210 
medium supplemented with  10%  newborn calf serum),  resuspended in 
$210 with 10 mM EDTA at 6  x  105 ceils/ml, and placed in a 37°C gyra- 
tory shaker incubator (200  rpm) for 15 min. The EDTA treatment was 
repeated, resulting in >95% single cells. The cells were then "recovered" 
by incubation with agitation in $210 with 5 % BSA (A7030; Sigma Chemical 
Co, St. Louis, MO) for 90 rain, which eliminated renmants of previously 
existing junctions. The cells remained as ,~95 %  single cells during this 
recovery period. The cells were then allowed to reaggregate and make new 
gap junctions. 
Freeze-Fracture  and Electron Microscopy to Quantify 
Gap Junction Structures 
Cells were reaggregated by centrifugation at 30 g for 5 rain to yield loose 
pellets in 17 ×  100 mm round bottom tubes, and then incubated for 60 rain 
at  37°C  in  a  5%  CO2  atmosphere.  Cell  pellets  were  fixed  in  2.5% 
glutaraldehyde in $210 medium for freeze-fracture and electron micros- 
copy.  F'~rther  processing  was  performed as  previously  reported  (27). 
Methods of quantitation have been described (42). Briefly,  an "interface" 
was defined as a fractured membrane area comprising at least 57/~m  2 (i.e., 
filling the screen at 10,000× on our microscope) and containing an indica- 
tion of cell apposition. Interfaces were scored according to the presence or 
absence of one or more formation plaques or gap junctions. "Formation 
plaques" (42) were defined as specialized membrane areas with clusters or 
arrays of  9-11 nm intramembranous particles. Aggregated 9-11 ran particles 
are defined here as individual gap junction channels. Formation plaque area 
and particle number measurements were performed as reported in detail 
elsewhere (42). 
Assay of  Dye Transfer 
We assayed dye transfer between two populations of Novikoff cells using 
a procedure with elements that are similar to a previously published method 
(50). One was loaded with the membrane-pormeant  dye calcein-AM, which 
is intracellularly cleaved to membrane-impermeant calcein, and the other 
was  labeled  with  the  lipophilic  dye,  1,1'-dioctadecyl-3,3,3',3'-tetra- 
methylindocarbocyanine  (DID. The cells were dissociated and recovered for 
1.5 h as described above. In separate tubes, calcein-AM (Molecular Probes, 
Eugene, OR) at a  dilution of 1,700×  from a  0.6  mM stock solution in 
DMSO (0.35 #M final concentration) or Dil (Molecular Probes) at a dilu- 
tion of 3,750× from a 0.85 mM stock solution in DMSO (0.2/~M final con- 
centration) was  added to the cells.  The two populations of cells were 
separately  pelleted,  resuspended  and  washed  three  times  with  $210 
medium. Calcein-containing cells (0.25  x  106) were then mixed with DiI- 
labeled cells (0.75 x  106) in 2 ml of $210 medium containing 5% BSA in 
a 35 mm tissue culture dish. Cells were routinely allowed to settle out and 
"reaggregate" in a 5% C(h incubator at 37°C. TPA was added either at the 
beginning or during the reaggregation period. After re,  aggregation, the cells 
were removed from the incubator and viewed with a Zeiss IM35 inverted 
microscope. Caleein was viewed with a fluorescein filter set 0BP 450-490, 
FT 510, LP 520). A 570 SP filter was added to the fluorescein emission 
set to eliminate low levels of orange DiI fluorescence observed when cells 
that were highly labeled with DiI were viewed. Rhodamine filters (BP 546, 
FT 580,  LP 590) were used to view DiI labeling. Phase views containing 
a total of up to several dozen cells per field in groups of two to eight cells 
were selected in a ~blind" manner without the microscopist knowing cell 
treatments. Phase and fluorescent views for ealcein and DiI were recorded 
using either a 35 mm camera with TMax film at 400 ASA or a Dage silicon- 
intensified target video camera, Panasonic video recorder and monitor. The 
percentages of cells that transferred dye were determined prior to treatment 
identification by dividing the number of DiI labeled cells that contained cal- 
cein (i.e., transfers) by the number of cell interfaces between calcein loaded 
and DiI cells (i.e., total). The complete set of data was collected from eight 
separate experiments. 
The effects of TPA on cell-cell aggregation were determined by totaling 
the number of aggregates of a given number of cells in a field (i.e., a four- 
cell cluster would be scored as one cluster under the "4  ~ heading). A total 
of 287 clusters of untreated control and 239 clusters of TPA treated cells 
from two separate days and several dozen fields were scored and the fre- 
quencies determined. 
Lucifer yellow was injected into nondissociated Novikoff cells as previ- 
ously described (28). The mean permeance of cell-cell interfaces between 
Novikoff ceU pairs was estimated according to published methods (8). 
Connexin 43 (Cx43) Metabolic Labeling, 
Immunoprecipitation and Western Transfer 
Dissociated Novikoff cells were labeled with [32P]O4 by incubation at 37°C 
for 3 h  with agitation at  1  ×  106 cells/ml in phosphate-free Dulbecco's 
modified Eagle medium (Sigma Chemical Co.) containing 3% BSA and 
0.25  mCi  [32p]Ojml  (New  England Nuclear,  Boston,  MA).  The cells 
were then allowed to "settle out" and reaggregate in the presence or absence 
of TPA for 1 h. 
Novikoff cells were  labeled with  [35S]methionine  for Cx43  half-life 
studies. Cells (20 x  106) were starved in methionine-free minimum essen- 
tial medium for 45 rain. The cells were then pelleted and vortexed in 10 
ml of fresh methionine-free minimum essential medium and 1 mCi [35S]- 
methionine (Amersham Corp., Arlington Heights, IL) was added. The cells 
were incubated for 2 h, pelleted, and chased with $210 medium containing 
3 % BSA for the times specified. 
Cx43 was immunoprecipitated from Novikoff cells, run on SDS-PAGE, 
and subjected to autoradiography as previously described (44), except 2/zg 
of monoclonal antibody  3068  (Chemicon,  Temecula,  CA)  specific for 
residues 252-270 of Cx43 and/or an antibody prepared to the amino termi- 
nal 20 residues (AT-2; generous gift of Barbara Yancey (Caltech, Pasadena, 
CA); described in reference 56) was used for each treatment. For [35S]me- 
thionine turnover studies, the stained/destained gels were soaked in Fluoro- 
Hance  (Research Products International,  Mount  Prospect,  IL)  prior to 
drying and autoradiography. Cx43 half-life determination was from densi- 
tometry of two autoradiographic exposures (3 and 6 d) from two different 
experiments. 
Cells were biotinylated on the cell surface using a protocol modified from 
a previously published procedure (36).  Approximately 2  x  107 cells per 
sample were dissociated and recovered as indicated above. The cells were 
then allowed to settle and reaggregate for 1 h at 37°C in the presence or 
absence of 50 nM TPA.  All subsequent steps were performed in a 4°C 
room. The cells were then pelleted and washed twice with 50 ml of 4oc, 
PBS (Celox Corp., Minneapolis, MN). NHS-LC-biotin (0.5 mg/mi in PBS; 
Pierce Chemical Co, Rockford, IL) was added to the pelleted cells, and the 
mixture was vortexed and placed on a rocker platform for 30 min. The cells 
were pelleted and then vortexed in 10 ml $210 medium with 10 mM glycine. 
After rocking for 15 min, the cells were pelleted and sonicated in 1.0 ml 
of lysis buffer (0.025 M Tris-HCl, 0.1 M NaC1, 10 mM EDTA, 50 mM NaF, 
500  ~M  Na3VO4,  0.5%  Triton  X-100,  1%  SDS,  0.02%  NAN3,  1 mM 
phenylmethylsulfonyl fluoride,  1 ~g/mi pepstatin,  10 ~g/ml aprotinin,  1 
~g/mi leupeptin, pH 8.0). After sonication, 0.8 mi of 50 mM Tris-HCl, con- 
taming 50 mM NaF, 500 ~M Na3VO,,, and the protease inhibitors at the 
above concentrations, was added and mixture was pelleted in a microfuge 
at 12,000 g for 10 rain. A portion (50/~1) was removed for the whole cell 
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din beads (crosslinked, 6% beaded agarose, Pierce Chemical Co.). Free 
d-biotin (20 ttg; Sigma Chemical Co.) was preincubated for 20 min with 
the immobilized avidin beads that were to be used for the control sample. 
After rocking the samples for 30 rain, the beads were pelleted at 2,000 g, 
and washed, once with lysis buffer without SDS, once with 50 mM Tris- 
HCI, 0.5% Twean-20, 2 M urea, 0.1 mM EDTA, pH 8.0, and twice with 
50 mM Tris-HCl, 0.5% Tween-20, 0.1 mM EDTA, pH 8.0. The beads find 
whole cell samples were treated with sample buffer (the beads also had 
d-biotin added to 5 raM).  Samples were boiled for 3 min, run on SDS- 
PAGE, and Western blotted to detect Cx43. 
For Western immunoblotting, SDS-PAGE of Novikoff cells was per- 
formed on 10.0% polyacrylamide gels following published methods (23). 
For the TPA treatment time course experiments, Novikoff cells were dis- 
sociated as described above.  Approximately 0.5  ×  106 cells were can- 
trifuged for 1 rain at 300 g and allowed to reaggregate at 37"C for the time 
indicated in the presence of TPA. After treatment for 15, 30, or 60 rain with 
TPA, cells were washed once in cold PBS and solubilized in Laemmli sam- 
ple buffer containing 2 mM EDTA, 50 mM NaF, 50/zM NaVO4, and pro- 
tease inhibitors (1/~g/ml pepstatin A, 1 tzg/ml leupeptin, 10 t~g/ml aproti- 
nin, and 2 mM PMSF). Cells that were not treated (NT) with TPA were 
reaggregated for 5-10 rain including the wash. Protein transfer was per- 
formed as previously described (20) and Cx43 was detected using antibody 
AT-2.  Primary antibody was detected using 125I-labeled goat anti-rabbit 
IgG (3 #Ci/blot; ICN Biomedicals, Irvine, CA). Autoradiography was per- 
formed using Kodak XAR 5 film overnight with an intensifying screen. 
Densitometry of autoradiographs was performed with NIH Image 1.44 
using a COHU CCD video camera and a frame grabber board (Data Trans- 
lation, Inc., San Diego, CA) connected to a Macintosh microcomputer. The 
public domain NIH Image program was written by Wayne Rasband at the 
U.S. National Institutes of Health (Gaithersburg, MD) and is available from 
the Internet by anonymous ftp from zippy.nimh.nih.gov or on floppy disk 
from NTIS (part number PB93-504868;  Springfield, VA). 
RNA Isolation from Novikoff ceUs 
Novikoff cells were grown and dissociated as described above. Cells were 
allowed to reaggregate for zero, one or two hours with or without 50 nM 
TPA. Cells were harvested by centrifugation at 1,000 g for 5 min. Cells were 
lysed and homogenized in a dounce with the addition of 7.5 ml cold 5 M 
guanidine-HC1,  0.2  M  sodium acetate,  0.5%  sodium  sarkosyl,  1  mM 
EDTA, and 0.5 M 2-mercaptoethanol. The suspension was repeatedly ex- 
tracted with phenol/chlornform/isoamyl alcohol (25:24:1),  followed by a 
single chloroform extraction, and RNA was selectively precipitated by add- 
ing one-half volume 95 % ethanol overnight at 20°C. After centrifugation 
at  12,000  g, pelleted RNA was resuspended in water treated with diethyl 
pyrocarbonate. Northern blots were obtained by electrophoresis of total 
RNA, 30/~g per lane, in formaldehyde  gels (0.8-1.0% agarose, 6.6% formal- 
dehyde, 20 told MOPS, pH 7.0, 2.5 mM sodium acetate,  1 mM EDTA). 
Gels were blotted to Zeta-Probe nylon membranes (Bio-Rad Laboratories, 
Beverly,  MA) by capillary action using 20×  SSPE. Blots were hybridized 
in 0.25 M NaCI, 7% SDS, 1 mM EDTA, 0.25 M sodium phosphate, pH 
7.0, 150 mg/ml herring sperm DNA, 50% formamide at 48°C. Filters were 
washed at 55°C with 0.2×  SSPE, 0.1% SDS. 
Probes for rodent connexins Cx26, Cx31.1,  Cx32, Cx33, Cx37,  Cx40, 
Cx46 (kindly provided by D. Paul, Harvard University, Boston, MA) and 
Cx43 cDNA clone G2 (the entire rat heart Cx43 coding sequence, kindly 
provided by E. Beyer, Washington University, St. Louis, MO; described in 
7) were radiolabeled (12) and used as hybridization probes for Northern 
analysis. 
Results 
Dye Transfer between Nondissociated Novikoff Cells 
Rapid dye transfer between neighboring cells has been ob.- 
served when the dye Lucifer yellow was microinjected into 
clusters of Novikoff hepatoma cells (8, 27-29). We wanted 
to determine if TPA treatment would affect dye transfer be- 
tween nondissociated cells. Approximately 80-90% of non- 
dissociated Novikoff  cells will transfer dye to adjacent cells. 
Treatment of these cells for 1 h with 50 nM TPA did not 
change the percentage that transferred dye. We also obtained 
a measure of the rate of gap junctional communication be- 
tween  cells  by  evaluating  "permeance"  values.  The  dye 
permeance of a cell-ceU interface (fully defined in reference 
8) depends on the total cross-sectional area and permeability 
of the gap junction. Comparison of the mean dye permeance 
of nondissociated Novikoff cells that  were TPA (50 nM) 
treated for 1 h (2.2  x  10-"  +  0.9  x  10-" cm3/s, n  =  17) 
with untreated cells (1.5  x  10  -H :1:0.9  x  10-" cm3/s, n  = 
20) showed no significant difference in the rate of dye trans- 
fer. Since cells treated for one hour continued to readily pass 
Lucifer yellow, TPA had little effect on the regulation or gat- 
ing  of gap  junctions  between  Novikoff cells  which  had 
formed dye-permeable gap junction channels prior to appli- 
cation of TPA. 
Inhibition of Gap Junction Assembly by TPA  : 
Dye Transfer 
We examined the effect of TPA on gap junction assembly be- 
tween Novikoff hepatoma cells which had been dissociated 
with  EDTA.  The dissociated cells were divided into two 
groups  and  labeled either with calcein-AM or DiI.  Non- 
fluorescent calcein-AM is cleaved by intraceUular esterases 
to fluorescent, membrane impermeant calcein (mol wt  = 
622) which is small enough to pass through gap junction 
channels. DiI labels membranes and is used here simply as 
a marker of potential recipient cells. The two populations of 
cells were washed, mixed and allowed to reaggregate for 1 h 
in a culture dish. 
Fig.  1 shows phase (A and a) and calcein (B and b) and 
DiI (C and c) fluorescence views of untreated control cells 
(A, B, and C) and cells TPA-treated during the reaggregation 
period (a, b, and c). Donor cells emitted calcein but not DiI 
fluorescence. Recipient cells were identified in the micro- 
scope by their yellow-green calcein fluorescence with the 
fluorescein filters and red DiI fluorescence with rhodarnine 
filters (shown in Fig. 1 in black and white). When evaluated 
for calcein, both donor and recipient cells were quite uni- 
formly fluorescent over the  entire cell,  but donors  were 
brighter than recipients. Cells were labeled with DiI in a dis- 
tinctly more punctate manner consistent with internal and 
plasma membrane localization of the label. In the untreated 
control cells shown in Fig.  1 (top), dye transfer was demon- 
strated from calcein-labeled donor cells to DiI labeled cells 
in 22 out of 32 calcein-DiI cell interfaces. One example of 
an interface and transfer between a donor and recipient cell 
is indicated by an arrow. Interfaces were only evaluated at 
the  light  microscope  level  and  may  not  represent  true 
cell-cell contact. In TPA-treated cells, no transfer was ob- 
served (Fig.  1, bottom). 
Data from over 1,300 cell-cell interfaces are summarized 
in Table I. When TPA (25 nM) was added to the cells at the 
onset of the 60 min reaggregation, dye transfer was detected 
at only 0.6% of the cell interfaces compared to 72% for the 
untreated control and 74 % for 4-u TPA, an inactive isomer. 
At 50 nM TPA no transfers were detected. Thus, TPA com- 
pletely blocked dye transfer between cells when assembly of 
new gap junction structures was required. 
TPA had no obvious influence on the ability of the cells 
to aggregate (Table II).  The size distributions of cell ag- 
gregates were nearly identical in the two treatments.  The 
cells appeared healthy by phase contrast microscopy even af- 
ter much higher concentrations of TPA and prolonged treat- 
ments. 
Lampe TPA Inhibits Gap Junction Assembly  1897 Figure 1. Transfer of  dye from calcein-loaded  cells to DiI-labeled cells. Phase (A and a) and calcein (B and b) and DiI (C and c) fluorescence 
views of untreated  control (A, B, and C) and 50 nM TPA-treated (a, b, and c) Novikoff cells.  TPA was only present  during the 60 min 
reaggregation  period (see Materials  and Methods for cell dissociation  and labeling  methods).  The arrow points out one cell pair showing 
calcein dye transfer  from the cell on the right to a DiI-labeled recipient  cell on the left.  The phase pictures  were taken with both visible 
and UV light  sources on. 
Table L The Effect of TPA on Calcein Transfer to Dil-labeled 
Cells 
Percent of 
Number of  interfaces 
Treatment  cell  interfaces*  with transfer 
Untreated control  683  72 
4-c~ TPA  (25  nM)  247  74 
TPA  (25  nM)  308  0.6 
TPA  (50 nM)  176  0 
* The complete set of data was compiled from eight separate experiments on 
different  days. 
Inhibition of Gap Junction Assembly by TPA: 
Freeze-Fracture Electron Microscopy 
Since freeze-fracture revealed that prior to reaggregation es- 
sentiaUy none of the EDTA-dissociated cells were linked by 
gap junctions (41), gap junctions observed after re,  aggrega- 
tion were products of nascent assembly. Formation plaques 
are areas of membrane specialization with clusters or arrays 
of putative  gap junction  precursors  (16,  17).  A  formation 
plaque from control cells reaggregated for 60 rain containing 
four  small  gap  junction  aggregates  is  shown  in  Fig.  2. 
Freeze-fracture  electron  microscopy of cells  re,  aggregated 
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of Clusters Containing Different Numbers of Cells 
Number of cells in a cluster 
Treatment  1  2  3  4  5  6  >6 
Control  32%  24%  15%  7%  6%  4%  12% 
TPA*  35%  23%  14%  9%  5%  2%  11% 
* 50 nM TPA was added at the beginning  of the 60 rain reaggregation  period. 
for 60 min in the presence of 50 nM TPA showed that the 
interfaces  between  Novikoff cells contained  no  formation 
plaques and no aggregated 9-11 nm intramembranous parti- 
cles (i.e., gap junction channels;  17). Control cell interfaces 
and those treated with 4-a TPA had values for aggregated gap 
junction channels per interface and formation plaque areas 
that were indistinguishable (Table III). 
The time course of TPA inhibition is shown in Fig. 3. Cells 
were reaggregated for the time specified before fixation. Un- 
treated control cells show a steady increase in aggregated gap 
junction channels with increasing time of reaggregation (D, 
solid line) consistent with earlier work (16, 42). To our sur- 
prise,  TPA  treated cells had  some gap junctions  channels 
present at 15 min before decreasing to near zero levels at 30 
and 60 min (o, dashed line).  Specifically, untreated control 
and TPA-treated cells that were allowed to reaggregate for 15 
rain before fixation had gap junctions at 63 and 49 % of the 
interfaces and formation plaque areas of 0.32 and 0.21 #m  2, 
respectively. The gap junctions that were present at 15 min 
of TPA treatment appeared to be newly formed,  since they 
were  smaller than junctions  between  nondissociated cells 
and had formation plaques that were morphologically con- 
sistent with nascent gap junctions (16). Since junctions were 
not detected at the end ofa 60-min reaggregation, TPA might 
Figure 2.  Freeze-fracture electron microscopy of a Novikoff cell 
membrane from a preparation of cells which had been reaggregated 
for 60  min.  Four small gap junction aggregates of 9-11 nm  in- 
tramembranous  particles can  be observed.  Bar equals  100  nm. 
When the cells were treated with TPA during the 1 h reaggregation, 
no gap junction aggregates or formation plaques were observed (not 
shown). 
Table IlL Freeze-Fracture Analysis of  the Effects of TPA on 
Gap Junction Assembly 
Gap junction  Formation  plaque 
Number of  channels/interface$  area #m2/interface 
Treatment*  cell interfaces  (x :k SEM)  (x +  SEM) 
Control  56  670  5- 44  0.27  5- 0.04 
4-0~ TPA  31  606  5- 57  0.25  +  0.03 
TPA  42  0  0 
BFA  48  154  5- 24  0.35  5- 0.06 
Monensin  53  160  +  19  0.32  5- 0.05 
* 50 nM TPA or 4-tx TPA was added  at the beginning  of the 60-min reaggre- 
gation  period. BFA (36/~M)  and monensin  (5/~M)  were  present  during  the recov- 
ery (2 h) and reaggregation  (1 h) periods. 
* Average number of intramembranous  panicles within gap junctions on a per 
interface basis. 
be  having  an  effect  on  gap  junction  disassembly  and/or 
turnover. 
Effects of TPA on Gap Junction Assembly~Disassembly 
TPA had a dramatic effect on net gap junction assembly. To 
determine the extent to which TPA was inhibiting assembly 
and/or  increasing disassembly, we added TPA  at different 
times during the reaggregation period and assayed dye trans- 
fer at the end of the 60-min reaggregation. If cells were reag- 
gregat~d for 15 min and then had TPA added for the remain- 
ing 45 min, 6 %  of the interfaces showed dye transfer after 
the 60 min reaggregation was complete (Table IV). After 30 
min of untreated reaggregation followed by 30 min with TPA 
present,  39 %  of the cells transferred dye.  Freeze-fracture 
data also demonstrated that when gap junctions were allowed 
to form for 15 or 30 min prior to TPA addition, some gap 
junction structures were detected after completion of the 60- 
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Figure 3.  Time course of TPA  inhibition of the assembly of gap 
junction channels at a cell-cell interface. Quantitative freeze-frac- 
ture  electron microscopy was  used to  count the number  of ag- 
gregated gap junction channels per interface in the absence ([], 
solid line) and presence (o, dashed line) of 50 nM TPA during the 
reaggregation time indicated. Cells were fixed immediately at the 
times indicated. Error bars indicate the standard error of the mean. 
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the Reaggregation Period 
Time of 50 nM  Dye transfer:  Electron microscopy: 
TPA addition  gap junction 
during 60-min  Percent  channels/interface 
reaggregation  n  transfer  (x  +  SEM) 
0  308  0  0 
15  198  6.1  177  ±  33 
30  259  39  261  ±  52 
none  683  72  577  ±  100 
min reaggregation (Table W). Therefore, addition of TPA af- 
ter re,  aggregation has proceeded for at least 15 min did not 
cause complete loss of gap junction structure and function. 
TPA must exert its most extensive effects on assembly with 
much less if any effect on disassembly. 
The Effects of TPA on Cx43 Phosphorylation, Protein, 
and mRNA Levels 
Novikoff cells contain Cx43 as detected by Westeru, North- 
ern, and polymerase chain reaction methods, but no mRNA 
has been detected for connexins 26, 31.1, 32, 33,  37, 40, or 
46  (17, 27,  28,  and data not shown).  Several investigators 
have shown that one band representing Cx43 in an immuno- 
blot is not phosphorylated and one to four bands thai run at 
higher  apparent  molecular  weight  correspond  to  phos- 
phorylated  forms of Cx43.  These phosphorylated species 
can be converted to the nonphosphorylated form upon alka- 
line phosphatase treatment (e.g., 5, 9,  19, 24, 34). Alkaline 
phosphatase treatment of Novikoff cell membrane prepara- 
tions has also been previously shown to convert the higher 
apparent molecular weight bands corresponding to Cx43 to 
a  single species (27). 
Since phosphorylation of Cx43 has been implicated in the 
assembly of gap junctions (25,  36), we wanted to determine 
if TPA  had  an  effect on  the  phosphorylation  of Cx43  in 
Novikoff cells.  Fig.  4  A  shows  immunoprecipitations  of 
Cx43  from cells metabolically labeled  with  [32p]o4. The 
first lane corresponds to an untreated control labeling and 
immunoprecipitation  performed  with  the  Cx43  antibody 
omitted (Fig. 4 A, No Ab); no band corresponding to Cx43 
is observed. Both the control and 4-c~ TPA lane show a band 
at 44 kD and less distinct but significant phosphorylated spe- 
cies between 44 and 52 kD. Addition of TPA (50 nM) during 
the reaggregation period led to a reduction of label at 44 kD 
with a corresponding increase in the abundance of higher ap- 
parent  molecular weight  forms detected  by densitometry. 
Despite these shifts, densitometric measurements of the la- 
bel from  44-52 kD showed essentially the same level of over- 
all labeling with  1 h  of TPA addition as with the controls 
(Untreated  control  =  8,120;  4-a  TPA  =  7,520;  TPA  = 
7,980;  arbitrary units).  Cx43 protein levels in the presence 
of TPA are considered below. 
Phosphorylation was also evaluated via Western immuno- 
blot analysis of Novikoff cell preparations NT or treated for 
15, 30, or 60 min with TPA from the onset of reaggregation 
(Fig. 4 B). Immunoblots of Novikoff  cells allowed much eas- 
ier evaluation of the time course of Cx43 phosphorylation 
and appeared to yield more distinct bands corresponding to 
phosphorylated  Cx43  than  the  32p  immunoprecipitates. 
Other investigators have also  observed less  distinct  Cx43 
band  patterns  with  32p  immunoprecipitation compared to 
[35S]methionine  metabolic labeling  or  immunoblots  (e.g., 
24, 35), possibly due to the high energy of the 32p radioiso- 
tope (35). The major Cx43 band in the untreated sample, 41 
kD, did not co-migrate with a phosphorylated species while 
two  higher  molecular  weight  bands  (44  and  48  kD)  co- 
migrated with bands present in phosphorylated Cx43 (Fig. 
4 A). In the presence of TPA, the 41-kD species appeared to 
be almost completely converted to the 44- and 48-kD spe- 
cies. Densitometric analysis (Fig. 4 C) of the different bands 
Figure 4. Immunoprecipitation 
and immunoblots of Cx43. An 
autoradiograph  representing 
32p-labeled Cx43 immunopre- 
cipitated  from Novikoff cells 
is  shown  in  A.  Cells  were 
metabolically  labeled  with 
[32P]O4 and  were  either  not 
treated  (No Ab and  Control) 
or treated with 50 nM TPA or 
50 nM of  the inactive analogue 
4-u TPA (as labeled)  for the 
l-h  reaggregation  period.  In 
the  No  Ab  lane,  no  Cx43 
monoclonal antibody was used 
in  the  immunoprecipitation 
incubation. The effects  of  TPA 
on Cx43 were also investigated 
by western immunoblotting as 
shown in R  Cells were either 
NT or were  treated  with  50 
nM  TPA for a  reaggregation 
period of 15, 30, or 60 rain as 
labeled. In C the mean Western immunoblot band density values from four separate experiments were normalized to their respective not 
treated,  41-kD band density values determined from densitometric  scans of the 41- (o), 44- (A), and 48-kD ([]) bands and were plotted 
with standard errors indicated. 
The Journal of Cell Biology, Volume 127,  1994  1900 from four separate experiments confirmed the  loss of the 
nonphosphorylated species and gain of the phosphorylated 
48-kD form. This result is in agreement with those of others 
who have documented similar changes in Cx43 phosphoryla- 
tion within  5  min of TPA addition  (5,  39).  Summation of 
the  densitometric  values  for the  three  species  showed  no 
significant change in Cx43 for up to 30 min of TPA treatment 
in  four separate experiments.  After 60  rain  of TPA treat- 
ment, the Cx43 protein levels dropped to an average of 72 % 
of the not treated, control level. Thus, up to 30 min of treat- 
ment with 50 nM TPA did not affect Novikoff Cx43 cellular 
protein levels even though gap junction  assembly (Fig.  3) 
was dramatically reduced at that time. These results may also 
explain  why  no  significant  increase  in  32p  incorporation 
into Cx43 was detected after 60 min of TPA treatment (Fig. 
4 A), since a 28 % loss in Cx43 would be expected. Treatment 
of cells with 4-a TPA for 30 min did not cause a shift in ap- 
parent molecular weight, and cells that were not allowed to 
reaggregate but were treated with TPA for 1 h showed a shift 
in the same manner as those that were reaggregated (results 
not shown). 
Northern analysis was performed to determine if the loss 
of Cx43  found  at  60  min  of TPA  treatment  was  due  to 
changes in Cx43 mRNA. TPA treatment (50 nM) of Novikoff 
cells during reaggregation for 1 or 2 h did not significantly 
affect Cx43 mRNA levels (Fig. 5). Densitometric values cal- 
culated from the autoradiograph for no reaggregation,  1 h 
control, 1 h TPA, 2 h control, and 2 h TPA were 1,826, 2,131, 
2,043, 2,310, and 2,210 (arbitrary units), respectively. Sev- 
eral  other  investigators  also  have observed  no  change  in 
Cx43 mRNA with TPA treatment in a  variety of cell types 
(1,  5,  9,  39). 
Since there was essentially no change in Cx43 mRNA, the 
loss of Cx43 at 60 min of TPA treatment observed in the im- 
munoblot may have been due to increased turnover of Cx43. 
Turnover  was  investigated  in  pulse-chase  [35S]methionine 
labeling  experiments  followed  by  immunoprecipitation  of 
Cx43 (Fig. 6). In these experiments, an excess of anti-Cx43 
polyclonal antibody was used for immunoprecipitation and 
some compression of the bands  (44  and 48  kD)  that cor- 
responded  to  phosphorylated  Cx43  was  observed due  to 
large amounts of IgG heavy chain. TPA treatment at the be- 
ginning  of the  chase period  eliminated  the  nonphosphor- 
Figure 5. TPA effect on Cx43 
mRNA. Cells were allowed to 
reaggregate  for 0,  1,  or 2  h 
with or without 50 nM TPA. 
Northern blots with 30 #g to- 
tal RNA/lane were hybridized 
to a radiolabeled  Cx43 clone 
G2 probe (see Materials  and 
Methods). A single band, de- 
termined to be 3 kb from the 
position  of  18S  and  28S 
rRNA,  was  detected  in  all 
samples. 
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Figure 6. TPA effect on Cx43 half-life. Cx43 was immunoprecipi- 
tated from [35S]methionine-labeled cells that had been chased for 
the  time  indicated.  In  A,  an  example  of  an  autoradiograph 
representing  Cx43 immunoprecipitated  from control  and 50 nM 
TPA-treated  cells  is  shown. The  bands  that  represent  phos- 
phorylated  Cx43 are labeled Cx43-P  and the nonphosphorylated 
band is labeled Cx43-NP. Note that in the TPA treated cells no NP 
form was found. In part B, plots of the mean relative densitometric 
values for total Cx43 (P  +  NP) in the absence ([]) and presence 
(o) of 50 nM TPA versus chase time are shown. 
ylated  form of Cx43  before the  cells  could  be aliquoted, 
pelleted, and lysed for immunoprecipitation (,o5 min). This 
result was consistent with the time course of conversion of 
the 41-kD band to 48 kD found in the immunoblot experi- 
ments.  Mean normalized densitometric values of the total 
Cx43 through the 4 h chase were fit to a single exponential 
decay. Control pulse-chase analysis yielded a 3.1-h half-life 
for Cx43, while TPA treatment reduced the half-life to 2 h. 
TPA reduced the half-life of Cx43 in each of three separate 
experiments relative to the untreated controls. 
Cx43 Protein Trafficking and TPA Inhibition of Gap 
Junction Assembly 
TPA could affect the trafficking of connexins to the plasma 
membrane or connexin-connexin assembly within the plasma 
membrane. We addressed these possibilities using a cell sur- 
face biotinylation technique to determine if TPA affects the 
level of Cx43 in the plasma membrane. A  TPA-dependent 
reduction in plasma membrane Cx43 could indicate that TPA 
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dissociation, recovery, and reaggregation, intact cells were reacted 
with a membrane-impermeant, biotin-linked molecule. TPA was 
either present (+TPA) or absent (-TPA, CON) during the reaggre- 
gation. After solubilization, whole cell portions (first three lanes) 
were removed and the rest was precipitated with avidin-agarose 
(latter three lanes). The avidin-agarose beads for the control sam- 
ple (CON) were preincubated with free biotin prior to addition of 
the solubilized cell mixture and showed no precipitated Cx43. 
acts  by  inhibiting  Cx43  trafficking  to  the  cell  surface. 
Novikoff  cells were dissociated, recovered and incubated for 
60 min with or without TPA. The cells were then cell surface 
biotinylated  using  NHS-LC-biotin,  a  membrane  imper- 
meant, amine reactive molecule with biotin attached via a 
spacer arm, in a modification (see Materials and Methods) 
of a previously published technique (36) which also studied 
plasma membrane Cx43. After solubilization and removal of 
an aliquot for determination of whole cellular levels of Cx43, 
biotinylated Cx43  was  avidin  precipitated and  Cx43  was 
quantitated in an immunoblot using Cx43 antibodies (Fig. 
7). The whole cell portion of the immunoblot shows that TPA 
does not cause large changes in the total Cx43, but does in- 
crease the abundance of the phosphorylated forms as previ- 
ously shown in Fig. 4. The avidin precipitated portion shows 
the phosphorylated and nonphosphorylated forms of Cx43 
that were present in the plasma membrane and able to bind 
NHS-LC-biotin.  When  no  TPA  was  present  during  the 
reaggregation of  the cells (-TPA), a clearly discernable band 
was observed that comigrated with the nonphosphorylated 
form of Cx43. This preference for biotinylation of the non- 
phosphorylated form has been previously observed for nor- 
mal  rat kidney ceils and  likely indicated a  preference for 
Cx43 that was in the bulk plasma membrane and not within 
a gap junction (36). When TPA was present (+TPA) both a 
nonphosphorylated and phosphorylated band were readily 
apparent. Densitometry from five separate biotinylation ex- 
periments showed that the sum of the amount of label in both 
forms for TPA treatment was 0.82 +  0.14 of the value for un- 
treated ceils. 
In the sample represented in the control lane (CON), the 
immobilized avidin beads were preincubated with free biotin 
to block the avidin binding sites; no Cx43 was discerned. An 
additional control where the NHS-LC-biotin was omitted in 
the cell surface reaction also showed a complete lack of Cx43 
(data not shown). A nonspecific, 66-kD band was observed 
in all samples that were precipitated with avidin beads or 
when a sample buffer extract of avidin beads alone (no cellu- 
lar component) was probed (not shown). This band was not 
observed in the whole cell extracts. 
Comparison of the level of Cx43  in the whole cell and 
avidin precipitated material indicated that 0.4-0.9% (n =  5) 
of the Cx43 molecules were biotinylated; a value which is 
only slightly less than the 1% efficiency  obtained for biotiny- 
lation of Cx43  in NRK cells (36).  These low efficiencies 
probably do not suggest that only 1% of the Cx43 is in the 
plasma membrane, but likely indicate that biotinylation is a 
relatively inefficient process  at 4°C  (36)  especially  since 
only two to three lysines are present on putative extracellular 
portions of Cx43. 
The role of protein trafficking in TPA-dependent inhibition 
of gap junction assembly  was  also investigated using  two 
well-known reagents that affect protein trafficking, brefeldin 
A  (BFA)  and  monensin.  BFA specifically inhibits protein 
transport  between  the  endoplasmic  reticulum  and  Golgi 
network (21).  Monensin,  a  Na  ÷ ionophore, impairs  Golgi 
function and protein trafficking past the trans-Golgi network 
(30). Both reagents have been shown to inhibit Cx43 protein 
trafficking to the plasma  membrane (37,  43).  Dissociated 
cells were incubated with agitation in the presence of BFA 
or monensin for 2 h and then reaggregated in the presence 
of BFA or monensin for 1 h. While the average number of 
gap junction channels per interface was reduced to less than 
one-third of control levels in both of these treatments (Table 
III), some assembly still occurred. This incomplete inhibi- 
tion of gap junction assembly, probably represents connexin 
proteins that are in the cytoplasm and have passed the sites 
of BFA or monensin blockage and/or that are already present 
in the plasma membrane. Other studies support the concept 
of gap junction assembly from connexin precursors present 
in the plasma membrane (11, 36).  This plasma membrane 
"pool" of  connexins, given time and cell-cell contact, assem- 
bled small yet functional gap junctions even in the presence 
of BFA or monensin.  However, when TPA was present no 
gap junctions were observed, consistent with activity at the 
plasma membrane, and not protein trafficking. 
Discussion 
Our results with short term (<1 h) TPA treatment are consis- 
tent with those of several others who have shown little or no 
change in Cx43 mRNA or cellular Cx43 protein levels (1, 5, 
9,  39).  With no obvious effect of TPA on transcription or 
translation of Cx43, two likely alternative points of gap junc- 
tion regulation include gap junction assembly and/or channel 
open time (channel gating). Although several investigators 
have concentrated on the latter point, differentiating between 
these two possibilities has proven to be very difficult to date. 
We approached this problem by using Novikoff cells which 
were either microinjected with dye to measure preexisting 
gap junctions or dissociated with EDTA to single cells and 
reaggregated to measure nascent gap junction assembly. 
When the dye Lucifer yellow was microinjected into one 
cell of a pair of Novikoff cells which had not been subjected 
to EDTA-dissociation, the rate of dye passage through gap 
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significantly change if TPA was  present for  1 h  prior to 
microinjection. That is,  these nondissociated cells,  which 
have moderate levels of gap junctional communication prior 
to TPA addition, were unaffected by TPA. Therefore, TPA 
must  affect Novikoff gap junctional  communication by a 
mechanism other than channel gating. 
TPA completely inhibited the assembly of functional gap 
junctions as measured in a dye transfer method with cells that 
had  been  dissociated  and  reaggregated.  Freeze-fracture 
electron microscopy confirmed that no gap junctions or for- 
mation plaques were present after 30-60 min of TPA treat- 
ment, while only slight changes were detected in the levels 
of total cellular Cx43 or levels of cell surface Cx43 that 
could be biotinylated. The observation that similar levels of 
plasma membrane Cx43 can be biotinylated with and with- 
out TPA treatment can be interpreted in at least two ways. 
The level of Cx43  in  the  plasma  membrane may not be 
significantly affected by TPA and Cx43 trafficking or turn- 
over may not be important in the inhibition of gap junction 
assembly. Alternatively, TPA could reduce the Cx43 plasma 
membrane concentration below a threshold level necessary 
to form gap junctions by inhibiting Cx43 trafficking or in- 
creasing Cx43 turnover, with the true difference between the 
control and TPA treated level of  plasma membrane Cx43 be- 
ing  masked by preferential biotinylation of nonjunctional 
Cx43 over Cx43 present within gap junction structures. Sev- 
eral pieces of data support the idea that Cx43 trafficking and 
turnover are not critical in TPA inhibition of gap junction as- 
sembly. Indeed, enough Cx43 is present after 15 min of TPA 
treatment to form gap junctions (Fig. 3), while evidence in- 
dicated there was no increase in protein turnover up to 30 
min of TPA treatment (Figs. 4 and 6). Experiments with BFA 
and monensin indicated that a  sizeable plasma membrane 
pool exists and inhibition of trafficking via these reagents can 
not eliminate gap junction assembly. Finally, Lucifer yellow 
readily  transferred  between  TPA-treated,  nondissociated 
cells, so a mechanism of increased gap junction disassembly 
or Cx43 turnover caused by TPA is unlikely. 
To further explore the possibility that TPA affects the dis- 
assembly of a  subset of gap junction structures,  TPA was 
added at different times during the reaggregation process. 
Cells that had been reaggregated for 15 or 30 min and then 
had TPA added for the remainder of the 60-min reaggrega- 
tion still transferred dye and had gap junctions present (Table 
IV). That is, 45 min in the presence of TPA is insufficient 
to dispose of gap junctions if they are first allowed to form 
for 15 min in the absence of TPA. Furthermore, the numbers 
of gap junction channels/interface after this 15-45 protocol 
were similar to those observed after 15 min of reaggregation 
(Fig. 3). Therefore, TPA had an immediate effect of inhibit- 
ing any additional gap junction assembly, while gap junc- 
tions formed prior to TPA treatment were stable in the pres- 
ence of TPA. Normal or TPA-enhanced disassembly of gap 
junctions which had not been fully stabilized could contrib- 
ute to the disappearance of gap junctions observed after 15 
min of reaggregation in the presence of TPA (Fig. 3).  The 
results in this study indicate that at least one stage or event 
that occurs after the transport of Cx43 to the plasma mem- 
brane is sensitive to TPA. These results are not necessarily 
in  conflict with  immunofluorescence studies  which  have 
documented reductions in punctate, plasma membrane im- 
munolabeling of Cx43 after 30 min-2 h of TPA treatment (1, 
5, 9), because dispersal of connexin molecules' from a gap 
junction plaque to the bulk plasma  membrane would de- 
crease the extent of Cx43 punctate labeling. In any case, dis- 
assembly of stable gap junctions can not be considered a ma- 
jor factor in the TPA-dependent inhibition of net gap junction 
assembly. 
Whether  TPA-dependent  phosphorylation  of Cx43  di- 
rectly affects gap junction  assembly  is  unclear.  A  direct 
correlation is difficult to prove and is far beyond the scope 
of this report. A putative phosphorylation event on Cx43 has 
been associated with the presence of Cx43 in the gap junc- 
tion versus the non-junctional plasma membrane (36). Possi- 
bly TPA-dependent phosphorylation of Cx43 negates or pre- 
vents this phosphorylation event. 
Since cell-cell adhesion and adhesion molecules appear to 
play an important role in gap junction assembly (18, 27, 35), 
the possibility that protein kinase C indirectly regulates gap 
junction assembly via changes in cell-cell adhesion should 
also be considered. Cell adhesion was addressed to a limited 
degree  in  this  study  by  counting the  number  of cells  in 
Novikoff cell aggregates;  TPA had no effect in this simple 
adhesion assay. Several reports indicate that TPA actually in- 
creases cell adhesion via molecules such as E-cadherin and 
members of the integrin family (14, 47, 52, 54). In addition, 
assembly studies with Novikoff cells reaggregated at nano- 
molar levels of extracellular calcium concentration where no 
adherens junctions should be present indicate that gap junc- 
tion assembly still occurs but is reduced by approximately 
60%  (Lampe  and  Johnson,  personal  communication). 
Therefore, TPA might have to be inhibiting multiple adhe- 
sion systems in order to eliminate gap junction assembly via 
general effects on adhesion.  This study, however, was not 
meant to define the role of adhesion in gap junction assem- 
bly,  The goal was  to define how TPA can have dramatic 
effects on cell communication by determining TPA-depen- 
dent changes in connexin levels, connexin cellular distribu- 
tion, and gap junction assembly/disassembly rates. 
In conclusion, our results with TPA treatment of Novikoff 
cells are consistent with a number of  other reports describing 
decreases in cell communication under different conditions, 
little or no changes in Cx43 mRNA or Cx43 protein levels, 
and rapid phosphorylation of Cx43 to higher apparent mo- 
lecular mass forms. Further, we have shown that TPA acts 
by inhibiting gap junction assembly. We developed quantita- 
tive assays for gap junction assembly that show that TPA 
completely blocked cell-cell communication on a time scale 
of  minutes rather than hours, but only when cell communica- 
tion was dependent on nascent gap junction assembly. If gap 
junction structures were present prior to TPA application, 
TPA had no effect on channel permeance for treatment times 
of up to 1 h. TPA caused less than a 20% reduction in the 
apparent level of Cx43 in the plasma membrane. Therefore, 
TPA must be affecting the ability of gap junctions to assem- 
ble within the plasma membrane even though Cx43 is pres- 
ent. Given that a rapid response of Novikoff  cells and many 
cell types to TPA is  Cx43 phosphorylation, a  regulatory 
mechanism involving protein kinase C-mediated Cx43 phos- 
phorylation is quite plausible. Alternatively, other events in- 
cluding cell-cell adhesion, may play a key role. 
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